KMT2A and leukemia: Furthermore, DS-1594a·HCl is a potential differentiation therapeutic, as it effectively reversed differentiation blockade by reducing clonogenic potential and induced cellular differentiation in MLL-AF9 oncogene-evoked murine AML-like cells and patient-derived MLL1-r leukemia cells.